|
ZVSA Zyversa Therapeutics Inc 1859007 |
| Income Statement |
|
Net Income
|
form10-q
|
-2,401,256 |
| Balance Sheet |
|
Current Assets
|
390,415 |
|
Assets
|
19,423,924 |
|
Current Liabilities
|
11,542,003 |
|
Liabilities
|
12,396,624 |
|
Equity
|
7,027,300 |
|
Shares Out
|
1,074,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-6,335,089 |
| Market Analysis |
Market Cap
|
2,418,612 |
|
Price
|
1.42 |
|
BVPS
|
6.54 |
|
PB
|
0.21 |
|
EPS
|
-100.63 |
|
PS
|
26.60 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ZVSA documents filed with the SEC.
ZVSA Filings
Clear
